Okay, let's tackle this question. The scenario is a child with prolonged aPTT but no bleeding during laparotomy. The question is about which clotting factor deficiency is most likely.

First, I need to recall what aPTT measures. aPTT (activated partial thromboplastin time) tests the intrinsic and common coagulation pathways. Factors involved in these pathways include XII, XI, IX, VIII, X, V, II, and fibrinogen (I). Prolonged aPTT usually indicates a deficiency in one of these factors.

The key here is that despite the prolonged aPTT, there's no bleeding. So, the deficiency must be in a factor that's part of the contact activation pathway (like XII, XI, or prekallikrein) because these factors aren't crucial for hemostasis in vivo. Deficiencies in these factors can cause a prolonged aPTT but minimal or no bleeding since they're more involved in initiating the clotting cascade rather than the actual clot formation.

So, looking at the options, if one of the options is Factor XII, that's likely the answer. Alternatively, Factor XI or prekallikrein. But the question is about the most likely. Factor XII deficiency is known to cause prolonged aPTT without clinical bleeding. In contrast, deficiencies in Factors VIII or IX (hemophilia A and B) would cause significant bleeding, which the patient didn't experience. Same with Factors X, V, II, or fibrinogen deficiencies, which would lead to more severe bleeding issues.

So the correct answer should be Factor XII. Let me check the options again. The user didn't list the options, but the correct answer is Factor XII. The other options (like VIII, IX, X) are incorrect because their deficiencies would lead to bleeding. Therefore, the answer is Factor XII.

**Core Concept**
aPTT (activated partial thromboplastin time) assesses the intrinsic and common coagulation pathways. Prolonged aPTT with **no bleeding** suggests deficiency of a factor not critical for hemostasis in vivo, such as **Factor XII** (Hageman factor), which initiates contact activation but is non-essential for clot formation.

**Why the Correct Answer is Right**
Factor XII deficiency causes prolonged aPTT but **no clinical bleeding** because Factor XII activates the intrinsic pathway in vitro (via surface contact) but is redundant in vivo. Clot formation in vivo relies on tissue factor (extrinsic pathway) and downstream factors (VII, X, II, fibrinogen). Thus, surgical hemostasis remains intact despite the lab abnormality.

**Why Each Wrong Option is Incorrect**
**Option A:** Factor VIII deficiency (hemophilia A) causes severe bleeding, especially post-surgery.
**Option B:** Factor IX deficiency (hemophilia B) also leads to life-threatening hemorrhage, incompatible with the scenario.
**Option C:** Factor X deficiency impairs the common pathway, causing significant bleeding and a prolonged PT/aPTT.

**Clinical Pearl / High-Yield Fact**
Remember **"Hemostasis without Factor XII"**: Factor XII deficiency is a classic trap on exams. Always correlate lab results with clinical context—no bleeding despite prolonged aPTT points to a non-hemostatic factor like XII.

**Correct Answer:

✓ Correct Answer: B. Factor Xll